AGA Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn’s Disease Guideline Summary - Guideline Central

Document Overview

Document Title
Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn’s Disease
Authoring Society

American Gastroenterological Association

Document Publication Date
May 27, 2021
Page Last Reviewed/Updated
May 5, 2026
Document Type
Guideline
Country of Publication
United States
Full Text Freely Available
Yes
Full Text Guideline
www.gastrojournal.org/article/S0016-5085(21)00645-4/fulltext?referrer=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F
Source Citation

Feuerstein JD, Ho EY, Shmidt E, Singh H, Falck-Ytter Y, Sultan S, Terdiman JP; American Gastroenterological Association Institute Clinical Guidelines Committee. AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease. Gastroenterology. 2021 Jun;160(7):2496-2508. doi: 10.1053/j.gastro.2021.04.022. PMID: 34051983.


Document Scope, Criteria, and Use Cases

Document Objectives
Outpatient medical management of moderate to severe luminal and fistulizing crohn's disease (CD).
Scope
Management, Treatment
Diseases/Conditions (MeSH)

D015212 - Inflammatory Bowel Diseases

D003424 - Crohn Disease

D005402 - Fistula

D005747 - Gastric Fistula

D007412 - Intestinal Fistula

D015212 - Inflammatory Bowel Diseases

D003424 - Crohn Disease

D005402 - Fistula

D005747 - Gastric Fistula

D007412 - Intestinal Fistula

Keywords
Crohn's disease, IBD, fistulas, fistulizing, inflammatory bowel disease
Target Patient Population
Patients with moderate to severe luminal and fistulizing crohn's disease (CD)
Inclusion Criteria
Male, Female, Adult, Older Adult
Health Care Settings
Ambulatory, Outpatient
Intended Users
Nurse, Nurse Practitioner, Physician, Physician Assistant

Recommendation Development Processes & Methodology

Supplemental Methodology Resource
Technical Review
Number of Source Documents
161
Includes peer/external review process?
Yes
Includes public comment process?
Yes
Methodologist involvement?
Yes
Patient involvement?
No
Includes multi-disciplinary group?
Yes
Includes systematic review?
Yes
Grades quality of strength of evidence?
Yes
Grades quality of strength of recommendation?
Yes
Discloses funding source?
Yes
Discloses conflicts of interest?
Yes
Includes benefits/harms analysis with recommendations?
No
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.